{"id":24447,"date":"2022-03-18T08:54:21","date_gmt":"2022-03-18T14:54:21","guid":{"rendered":"https:\/\/saluddigital.com\/?p=24447"},"modified":"2025-10-21T10:07:07","modified_gmt":"2025-10-21T16:07:07","slug":"cientificos-desarrollan-app-movil-que-detecta-riesgo-de-infarto-a-traves-de-informacion-genetica","status":"publish","type":"post","link":"https:\/\/saluddigital.com\/en\/noticias\/cientificos-desarrollan-app-movil-que-detecta-riesgo-de-infarto-a-traves-de-informacion-genetica\/","title":{"rendered":"Scientists develop mobile app that detects risk of heart attack through genetic information"},"content":{"rendered":"
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Genomics researchers at the Scripp Research Translational Institute have developed a mobile application that is capable of calculating the genetic risk of suffering heart attacks. <\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

The application called MyGeneRank can predict a person's genetic risk of having a heart attack. A study on this technological and medical advance was published in npj Digital Medicine.<\/p>

The study details that the development of MyGeneRank required information from 23andMe, a genetic testing company, and the participation of 721 people. The data collected was on the risk of coronary heart disease based on DNA data from the participants.<\/p>

The study shows that participants with high-risk scores were more likely to use cholesterol-lowering therapies, compared to participants with low scores.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

"We observed approximately twice the rate of statin initiation in the high genetic risk group versus the low genetic risk group, indicating that strategies such as this could make a large contribution to public health, as heart disease is the leading cause of death worldwide,\u201d explained study lead author Dr. Ali Torkamani, director of Genomics and Genome Informatics at Scripps Research Translational Institute.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t

\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

In this sense, the method consisted of alerting the participants about their risk of having a heart attack through the mobile app. This represents a model that can be replicated to promote health care and an early approach to medical care and possible diagnosis.<\/p>

For his part, Dr. Evan Muse, cardiologist, leader of cardiovascular genomics at the Institute and co-author of the study, explained that: "We now have the opportunity to integrate a person's genetics into their evaluation of cardiovascular health to help them better understand their individualized risk and empower them to make necessary modifications, including the addition of statin therapy, to their risk factor optimization plans.\u201d<\/p>

Torkamani explains that when a person knows their genetic risk, even if it is low, they can generate a change in their lifestyle, such as a better diet or physical activity.<\/p>

Learn more about this application in the following link: https:\/\/mygenerank.scripps.edu\/<\/a><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/i><\/span>\n\t\t\t\t\t\t\t\t<\/i><\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t BIBLIOGRAPHY<\/a>\n\t\t\t\t\t<\/div>\n\n\t\t\t\t\t

EUREKALERT<\/strong><\/p>

https:\/\/www.eurekalert.org\/news-releases\/946354<\/a><\/p>

HEALTH IT ANALYTICS <\/strong><\/p>

https:\/\/healthitanalytics.com\/news\/smartphone-app-can-help-detect-genetic-risk-for-heart-attacks<\/a> \u00a0<\/p><\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>","protected":false},"excerpt":{"rendered":"

Investigadores de gen\u00f3mica en el Scripp Research Tanslational Institute, desarrollaron una aplicaci\u00f3n m\u00f3vil que es capaz de calcular el riesgo gen\u00e9tico de padecer infartos. La aplicaci\u00f3n llamada MyGeneRank, puede predecir el riesgo gen\u00e9tico que tiene una persona de padecer un infarto. Un estudio sobre este avance tecnol\u00f3gico y m\u00e9dico fue publicado en npj Digital Medicine. El estudio detalla que para el desarrollo de MyGeneRank, fue necesaria la informaci\u00f3n de 23andMe, una compa\u00f1\u00eda de pruebas gen\u00e9ticas y la participaci\u00f3n de 721 personas. Los datos recolectados fueron sobre el riesgo de enfermedad coronaria basada en datos del ADN de los participantes. El estudio muestra que los participantes con puntajes de alto riesgo ten\u00edan m\u00e1s probabilidades de utilizar terapias para la reducci\u00f3n del colesterol, en comparaci\u00f3n a los participantes con puntajes bajos. \u201cObservamos aproximadamente el doble de la tasa de inicio de estatinas en el grupo de alto riesgo gen\u00e9tico frente al grupo de bajo riesgo gen\u00e9tico, lo que indica que estrategias como esta podr\u00edan hacer una gran contribuci\u00f3n a la salud p\u00fablica, ya que la enfermedad card\u00edaca es la principal causa de muerte en todo el mundo”, explic\u00f3 el autor principal del estudio, el Dr. Ali Torkamani, director de Gen\u00f3mica e Inform\u00e1tica del Genoma en el Scripps Research Translational Institute. En este sentido, el m\u00e9todo consisti\u00f3 en alertar a trav\u00e9s de la app m\u00f3vil a los participantes sobre su riesgo de padecer un infarto. Lo que representa un modelo que puede ser replicado para promover el cuidado de la salud y un acercamiento temprano a la atenci\u00f3n m\u00e9dica y un posible diagn\u00f3stico. Por su parte, el Dr. Evan Muse, cardi\u00f3logo, l\u00edder de gen\u00f3mica cardiovascular en el Instituto y coautor del estudio, explic\u00f3 que: \u201cAhora tenemos la oportunidad de integrar la gen\u00e9tica de una persona en su evaluaci\u00f3n de salud cardiovascular para ayudarlos a comprender mejor su riesgo individualizado y empoderarlos para realizar las modificaciones necesarias, incluida la adici\u00f3n de la terapia con estatinas, a sus planes de optimizaci\u00f3n de factores de riesgo\u201d. Torkamani, explica que cuando una persona conoce su riesgo gen\u00e9tico, aunque este sea bajo, puede generar el cambio en su estilo de vida, como una mejor alimentaci\u00f3n o la pr\u00e1ctica de actividad f\u00edsica. Conoce m\u00e1s sobre esta aplicaci\u00f3n en el siguiente enlace: https:\/\/mygenerank.scripps.edu\/ BIBLIOGRAF\u00cdA EUREKALERT https:\/\/www.eurekalert.org\/news-releases\/946354 HEALTH IT ANALYTICS https:\/\/healthitanalytics.com\/news\/smartphone-app-can-help-detect-genetic-risk-for-heart-attacks  <\/p>","protected":false},"author":1,"featured_media":24448,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[3395,3393,160],"tags":[145],"class_list":["post-24447","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-apps-moviles-e-internet-de-las-cosas","category-inteligencia-artificial-y-ciencia","category-noticias","tag-noticias"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/saluddigital.com\/en\/wp-json\/wp\/v2\/posts\/24447","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/saluddigital.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/saluddigital.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/saluddigital.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/saluddigital.com\/en\/wp-json\/wp\/v2\/comments?post=24447"}],"version-history":[{"count":0,"href":"https:\/\/saluddigital.com\/en\/wp-json\/wp\/v2\/posts\/24447\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/saluddigital.com\/en\/wp-json\/wp\/v2\/media\/24448"}],"wp:attachment":[{"href":"https:\/\/saluddigital.com\/en\/wp-json\/wp\/v2\/media?parent=24447"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/saluddigital.com\/en\/wp-json\/wp\/v2\/categories?post=24447"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/saluddigital.com\/en\/wp-json\/wp\/v2\/tags?post=24447"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}